1/30
07:00 am
dgx
Quest Diagnostics (NYSE:DGX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $210.00 price target on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $210.00 price target on the stock.
1/30
06:09 am
dgx
Quest Diagnostics upgraded to Overweight from Equal Weight at Barclays
Low
Report
Quest Diagnostics upgraded to Overweight from Equal Weight at Barclays
1/30
06:09 am
dgx
Quest Diagnostics upgraded to Overweight from Equal Weight at Barclays
Low
Report
Quest Diagnostics upgraded to Overweight from Equal Weight at Barclays